Teprotumumab News

← Back to News Overview

---

Teprotumumab currently has 0 news articles, with 20 predicted indications.

This page combines the AI-predicted indications for Teprotumumab with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

• Original indication: Treatment of moderate to severe thyroid eye disease (TED).
• Evidence level: L5
• Predicted indications (20):
  • monosomy X (99.8%)
  • esophageal varices with bleeding (99.6%)
  • esophageal varices without bleeding (99.6%)
  • mixed gonadal dysgenesis (99.5%)
  • mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies (99.4%)
  • Turner syndrome due to structural X chromosome anomalies (99.4%)
  • mosaic monosomy X (99.4%)
  • sex chromosome disorder of sex development (99.3%)
  • varicose disease (99.3%)
  • X chromosome number anomaly (99.3%)
  • gonadal dysgenesis (99.0%)
  • Turner syndrome (99.0%)
  • 46,XY disorder of gonadal development (99.0%)
  • male infertility due to gonadal dysgenesis (98.9%)
  • exocrine pancreatic insufficiency (98.9%)
  • precocious puberty (98.8%)
  • ichthyosis, X-linked, without steroid sulfatase deficiency (98.8%)
  • disorder of other vitamins and cofactors metabolism and transport (98.6%)
  • dappled diaphyseal dysplasia (98.6%)
  • xanthomatosis (disease) (98.6%)

View full drug report →

Related News (0)

No related news yet. When news mentions this drug, it will be collected and shown here automatically.

Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.